(Q37828130)

23 August 2017

1 reference

title

Reassessment of benefit-risk ratio and treatment algorithms for antiarrhythmic drug therapy after the cardiac arrhythmia suppression trial (English)

1 reference

23 August 2017

0 references

Anderson JL

1

1 reference

23 August 2017

language of work or name

1 reference

1 November 1990

1 reference

The Journal of Clinical Pharmacology

23 August 2017

published in

1 reference

23 August 2017

volume

30

1 reference

23 August 2017

issue

11

1 reference

23 August 2017

page(s)

981-989

1 reference

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

The Cardiac Arrhythmia Suppression Trial: background, interim results and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Effect of antiarrhythmic drugs on mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Efficacy of recainam, a new antiarrhythmic drug, for control of ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Summary of efficacy and safety of flecainide for supraventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03582.X

10.1002/J.1552-4604.1990.TB03582.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference